These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Nicotine-replacement products in smoking cessation: a review. Alsagoff F; Lee HP Singapore Med J; 1993 Dec; 34(6):505-10. PubMed ID: 8153711 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamics of nicotine: implications for rational treatment of nicotine addiction. Benowitz NL Br J Addict; 1991 May; 86(5):495-9. PubMed ID: 1859911 [TBL] [Abstract][Full Text] [Related]
6. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587 [TBL] [Abstract][Full Text] [Related]
7. Nicotine chewing gum and nicotine patch. Fagerström KO; Tönnesen P Wien Med Wochenschr; 1995; 145(4):77-82. PubMed ID: 7778323 [TBL] [Abstract][Full Text] [Related]
9. Cigarette smoking and nicotine addiction. Benowitz NL Med Clin North Am; 1992 Mar; 76(2):415-37. PubMed ID: 1548969 [TBL] [Abstract][Full Text] [Related]
10. Transdermal nicotine: reduction of smoking with minimal abuse liability. Pickworth WB; Bunker EB; Henningfield JE Psychopharmacology (Berl); 1994 Jun; 115(1-2):9-14. PubMed ID: 7862918 [TBL] [Abstract][Full Text] [Related]
11. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Benowitz NL; Zevin S; Jacob P Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580 [TBL] [Abstract][Full Text] [Related]
12. Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: a review. Le Houezec J Int J Tuberc Lung Dis; 2003 Sep; 7(9):811-9. PubMed ID: 12971663 [TBL] [Abstract][Full Text] [Related]
13. Pharmacology of nicotine: addiction and therapeutics. Benowitz NL Annu Rev Pharmacol Toxicol; 1996; 36():597-613. PubMed ID: 8725403 [TBL] [Abstract][Full Text] [Related]
14. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving. Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055 [TBL] [Abstract][Full Text] [Related]
15. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking. Rose JE; Behm FM; Westman EC Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622 [TBL] [Abstract][Full Text] [Related]
16. Nicotine dependence: a preventable risk factor for other diseases. Cohen C; Henningfield JE J Gen Intern Med; 1990; 5(5 Suppl):S73-8. PubMed ID: 2231070 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic determinants of tobacco self-administration by humans. Henningfield JE; Goldberg SR Pharmacol Biochem Behav; 1988 May; 30(1):221-6. PubMed ID: 3051047 [TBL] [Abstract][Full Text] [Related]
18. Nicotine dependence. Interface between tobacco and tobacco-related disease. Henningfield JE; Nemeth-Coslett R Chest; 1988 Feb; 93(2 Suppl):37S-55S. PubMed ID: 3276461 [No Abstract] [Full Text] [Related]
19. Similar precipitated withdrawal effects on intracranial self-stimulation during chronic infusion of an e-cigarette liquid or nicotine alone. Harris AC; Muelken P; Smethells JR; Krueger M; LeSage MG Pharmacol Biochem Behav; 2017 Oct; 161():1-5. PubMed ID: 28867606 [TBL] [Abstract][Full Text] [Related]